New Issue: Unigene Laboratories completes $2.5 million in private placement

By Sheri Kasprzak

Atlanta, Jan. 5 - Unigene Laboratories Inc. said it raised $2,500,002 in a private placement of stock.

The company sold 1,302,140 shares at about $1.91 each to Fusion Capital Fund II LLC on Dec. 29 and Dec. 30.

Based in Fairfield, N.J., Unigene manufactures injectable calcitonin products to prevent bone loss.

Issuer:	Unigene Laboratories Inc.
Issue:	Stock
Amount:	$2,500,002
Shares:	1,302,140
Price:	$1.91
Warrants:	No
Investor:	Fusion Capital Fund II LLC
Settlement date:	Dec. 30
Stock price:	$2.20 at close Dec. 30

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.